Twist Bioscience to Report Fiscal 2025 Second Quarter Financial Results on Monday, May 5, 2025
Twist Bioscience (NASDAQ: TWST) has announced it will release its fiscal 2025 second quarter financial results on Monday, May 5, 2025, before market opening. The company will host a conference call and live audio webcast for analysts and investors at 8:00 AM Eastern Time to discuss the quarterly results and provide a business update.
Participants interested in joining via telephone must pre-register through the company's Investor Relations website. The financial results press release will be available on the company's website in the Investor Relations section. A webcast replay will be accessible for two weeks following the call.
Twist Bioscience (NASDAQ: TWST) ha annunciato che rilascerà i risultati finanziari del secondo trimestre fiscale 2025 lunedì 5 maggio 2025, prima dell'apertura del mercato. L'azienda ospiterà una conferenza telefonica e un webcast audio dal vivo per analisti e investitori alle 8:00 AM Eastern Time per discutere i risultati trimestrali e fornire un aggiornamento aziendale.
I partecipanti interessati a unirsi tramite telefono devono preregistrarsi attraverso il sito web delle Relazioni con gli Investitori dell'azienda. Il comunicato stampa sui risultati finanziari sarà disponibile sul sito web dell'azienda nella sezione Relazioni con gli Investitori. Una registrazione del webcast sarà accessibile per due settimane dopo la chiamata.
Twist Bioscience (NASDAQ: TWST) ha anunciado que publicará sus resultados financieros del segundo trimestre fiscal 2025 el lunes 5 de mayo de 2025, antes de la apertura del mercado. La compañía llevará a cabo una conferencia telefónica y una transmisión de audio en vivo para analistas e inversores a las 8:00 AM Eastern Time para discutir los resultados trimestrales y proporcionar una actualización empresarial.
Los participantes interesados en unirse por teléfono deben preregistrarse a través del sitio web de Relaciones con Inversores de la compañía. El comunicado de prensa de los resultados financieros estará disponible en el sitio web de la compañía en la sección de Relaciones con Inversores. Una grabación de la transmisión estará accesible durante dos semanas después de la llamada.
트위스트 바이오사이언스 (NASDAQ: TWST)는 2025 회계연도 2분기 재무 결과를 2025년 5월 5일 월요일, 시장 개장 전 발표할 것이라고 발표했습니다. 회사는 동부 표준시 기준 오전 8시에 애널리스트와 투자자를 위한 컨퍼런스 콜 및 라이브 오디오 웹캐스트를 개최하여 분기 결과를 논의하고 사업 업데이트를 제공할 예정입니다.
전화로 참여하고자 하는 참가자는 회사의 투자자 관계 웹사이트를 통해 사전 등록해야 합니다. 재무 결과에 대한 보도 자료는 회사 웹사이트의 투자자 관계 섹션에서 확인할 수 있습니다. 웹캐스트 재생은 통화 후 2주 동안 접근 가능합니다.
Twist Bioscience (NASDAQ: TWST) a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre fiscal 2025 le lundi 5 mai 2025, avant l'ouverture des marchés. L'entreprise organisera une conférence téléphonique et un webinaire audio en direct pour les analystes et les investisseurs à 8h00, heure de l'Est afin de discuter des résultats trimestriels et de fournir une mise à jour commerciale.
Les participants intéressés à se joindre par téléphone doivent préenregistrer via le site web des Relations avec les Investisseurs de l'entreprise. Le communiqué de presse des résultats financiers sera disponible sur le site web de l'entreprise dans la section Relations avec les Investisseurs. Un enregistrement du webinaire sera accessible pendant deux semaines après l'appel.
Twist Bioscience (NASDAQ: TWST) hat angekündigt, dass es die finanziellen Ergebnisse des zweiten Quartals des Geschäftsjahres 2025 am Montag, den 5. Mai 2025, vor Markteröffnung veröffentlichen wird. Das Unternehmen wird um 8:00 Uhr Eastern Time eine Telefonkonferenz und einen Live-Audio-Webcast für Analysten und Investoren veranstalten, um die Quartalsergebnisse zu diskutieren und ein Unternehmensupdate zu geben.
Teilnehmer, die telefonisch teilnehmen möchten, müssen sich über die Investor Relations-Website des Unternehmens vorab registrieren. Die Pressemitteilung zu den finanziellen Ergebnissen wird im Bereich Investor Relations auf der Unternehmenswebsite verfügbar sein. Eine Aufzeichnung des Webcasts wird zwei Wochen nach dem Anruf zugänglich sein.
- None.
- None.
Company to host conference call at 8:00 AM ET
The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks.
About Twist Bioscience Corporation
Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research.
Follow us on LinkedIn | X | YouTube | Instagram | Bluesky
View source version on businesswire.com: https://www.businesswire.com/news/home/20250414096128/en/
For Investors:
Angela Bitting
SVP, Corporate Affairs
925-202-6211
abitting@twistbioscience.com
For Media:
Amanda Houlihan
Communications Manager
774-265-5334
ahoulihan@twistbioscience.com
Source: Twist Bioscience Corporation
FAQ
When will Twist Bioscience (TWST) release its Q2 2025 earnings?
What time is Twist Bioscience's (TWST) Q2 2025 earnings call?
How can investors access Twist Bioscience's (TWST) Q2 2025 earnings call?
How long will Twist Bioscience's (TWST) Q2 2025 earnings call replay be available?
